BioInfra Life Science Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '20 Mar 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Operating Revenue	1,779	1,875	1,551	1,370	1,550
Other Revenue	-0	-	-	-	0
Revenue	1,779	1,875	1,551	1,370	1,550
Revenue Growth (YoY)	27.54%	20.82%	13.25%	-11.60%	-
Cost of Revenue	953.44	978.91	723.68	622.76	662.63
Gross Profit	825.48	895.63	827.76	747.16	887.05
Selling, General & Admin	2,916	2,944	2,992	2,721	3,381
Research & Development	1,123	1,115	1,162	975.6	941.9
Other Operating Expenses	23.15	21.81	22.09	20.5	22.44
Operating Expenses	4,379	4,265	4,442	3,866	4,413
Operating Income	-3,554	-3,369	-3,614	-3,119	-3,526
Interest Expense	-295.64	-205.65	-27.2	-60.16	-55.3
Interest & Investment Income	161.63	140.74	125.19	76.52	145.21
Currency Exchange Gain (Loss)	1.53	-2.38	11.7	-37.42	43.17
Other Non Operating Income (Expenses)	76.79	80.69	-343.42	72.88	19.79
EBT Excluding Unusual Items	-3,610	-3,356	-3,848	-3,067	-3,373
Gain (Loss) on Sale of Investments	15.49	77.2	76.07	-	-
Gain (Loss) on Sale of Assets	-	-	-35.41	-112.69	-55.59
Asset Writedown	-	-	-	-816.23	-1,175
Pretax Income	-3,594	-3,278	-3,807	-3,996	-4,603
Net Income	-3,594	-3,278	-3,807	-3,996	-4,603
Net Income to Common	-3,594	-3,278	-3,807	-3,996	-4,603
Shares Outstanding (Basic)	13	13	14	13	13
Shares Outstanding (Diluted)	13	13	14	13	13
Shares Change (YoY)	-2.59%	-1.87%	6.28%	1.42%	-
EPS (Basic)	-266.28	-243.11	-277.01	-309.00	-361.00
EPS (Diluted)	-266.28	-243.11	-277.01	-309.00	-361.00
Free Cash Flow	-2,955	-2,989	-4,112	-3,607	-3,760
Free Cash Flow Per Share	-218.93	-221.65	-299.20	-278.95	-294.93
Gross Margin	46.40%	47.78%	53.35%	54.54%	57.24%
Operating Margin	-199.77%	-179.72%	-232.93%	-227.65%	-227.50%
Profit Margin	-202.03%	-174.89%	-245.38%	-291.67%	-297.02%
Free Cash Flow Margin	-166.11%	-159.45%	-265.03%	-263.31%	-242.66%
EBITDA	-3,178	-3,022	-3,341	-2,940	-3,398
EBITDA Margin	-178.62%	-161.21%	-215.33%	-214.63%	-219.25%
D&A For EBITDA	376.3	347.07	273.1	178.4	127.89
EBIT	-3,554	-3,369	-3,614	-3,119	-3,526
EBIT Margin	-199.77%	-179.72%	-232.93%	-227.65%	-227.50%
Advertising Expenses	-	62.51	47.7	47.05	53.05

Updated May 19, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.